Drug Database
Back to search

Japan· JP-3132002B1034

ニコチン酸アミド

A nicotinamide product containing ニコチン酸アミド, registered in Japan by ＮＩＳＳＨＡゾンネボード製薬, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

On Japan’s NHI price listATC A11HA01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedニコチン酸アミドATCA11HA01REGISTER NO.JP-3132002B1034PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ニコチン酸アミドAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nicotinamide is registered in 8 of 19 countries.

Countries holding a registration under ATC A11HA01 (nicotinamide), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 5 of them publish a price we can compare per daily dose
Search nicotinamide products by name

Nicotinamide · ATC A11HA01

8 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ニコチン酸アミド
Manufacturer
ＮＩＳＳＨＡゾンネボード製薬
Country
Japan (JP)
ATC code
A11HA01
ATC class
Nicotinamide
Defined daily dose
0.15 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

83 interactions on record for nicotinamide.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nicotinamide against other medicinesHow interaction checks work

Nicotinamide · interactions on record

83 records

  • 7 severe
  • 75 moderate
  • 1 minor

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nicotinamide in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nicotinamide products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Belgium · Nicotinamide Sterop
  • Germany · Nicotinamid Axicur
  • France · Nicobion, Nicotinamide Renaudin
  • United Kingdom (Northern Ireland) · Freederm, Freederm Treatment
  • Ireland · Nicam
  • Italy · Nicotinamide Idi
  • Poland · Vitaminum Pp Polfarmex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4bc3e375-e61c-42cf-b692-11e5f99385e1
GET /v1/drugs/4bc3e375-e61c-42cf-b692-11e5f99385e1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１０％１ｇ",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3132002B1034",
  "category": "内用薬",
  "price_yen": 10.7,
  "generic_name": "ニコチン酸アミド",
  "product_name_jp": null,
  "therapeutic_class": "3132",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about nicotinamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console